Carregant...
Tipus de document
ArticleData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/181016
Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The nucleotide analogue azacitidine (AZA) is currently the best treatment option for patients with high-risk myelodysplastic syndromes (MDS). However, only half of treated patients respond and of these almost all eventually relapse. New treatment options are urgently needed to improve the clinical management of these patients. Here, we perform a loss-of-function shRNA screen and identify the histone acetyl transferase and transcriptional co-activator, CREB binding protein (CBP), as a major regulator of AZA sensitivity. Compounds inhibiting the activity of CBP and the closely related p300 synergistically reduce viability of MDS-derived AML cell lines when combined with AZA. Importantly, this effect is specific for the RNA-dependent functions of AZA and not observed with the related compound decitabine that is only incorporated into DNA. The identification of immediate target genes leads us to the unexpected finding that the effect of CBP/p300 inhibition is mediated by globally down regulating protein synthesis. © 2021. The Author(s).
Matèries
Matèries (anglès)
Citació
Citació
DIESCH, Jeannine, PANNÉRER, Marguerite marie le, WINKLER, René, CASQUERO, Raquel, MUHAR, Matthias, VAN DER GARDE, Mark, MAHER, Michael, MARTÍNEZ HERRÁEZ, Carolina, BECH SERRA, Joan j., FELLNER, Michaela, RATHERT, Philipp, BROOKS, Nigel, ZAMORA, Lurdes, GENTILELLA, Antonio, TORRE, Carolina de la, ZUBER, Johannes, GÖTZE, Katharina s., BUSCHBECK, Marcus. Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis. _Nature Communications_. 2021. Vol. 12, núm. 1. [consulta: 23 de gener de 2026]. ISSN: 2041-1723. [Disponible a: https://hdl.handle.net/2445/181016]